Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
8.14
-0.26 (-3.10%)
At close: Jun 27, 2025, 4:00 PM
8.10
-0.04 (-0.49%)
After-hours: Jun 27, 2025, 6:44 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $579.33 million as of June 27, 2025. Its market cap has decreased by -57.08% in one year.
Market Cap
579.33M
Enterprise Value
59.15M
1-Year Change
-57.08%
Ranking
Category
Stock Price
$8.14
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $579.33M, an increase of 136.08%. That is a compound annual growth rate of 7.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 597.80M | -62.83% |
Dec 31, 2024 | 1.61B | 24.44% |
Dec 29, 2023 | 1.29B | -17.18% |
Dec 30, 2022 | 1.56B | -33.50% |
Dec 31, 2021 | 2.35B | -6.40% |
Dec 31, 2020 | 2.51B | 28.51% |
Dec 31, 2019 | 1.95B | -4.07% |
Dec 31, 2018 | 2.03B | 97.53% |
Dec 29, 2017 | 1.03B | -4.93% |
Dec 30, 2016 | 1.08B | 82.97% |
Dec 31, 2015 | 591.80M | 17.51% |
Dec 31, 2014 | 503.60M | 87.28% |
Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 715.94B |
Johnson & Johnson | 366.66B |
AbbVie | 331.36B |
Novo Nordisk | 301.06B |
UnitedHealth Group | 276.74B |
Abbott Laboratories | 232.56B |
Novartis AG | 231.01B |
AstraZeneca | 216.45B |